SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004605
Filing Date
2018-05-10
Accepted
2018-05-10 14:54:22
Documents
81
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q depo-20180331x10q.htm 10-Q 2345773
2 EX-10.1 depo-20180331ex1016006c0.htm EX-10.1 923231
3 EX-31.1 depo-20180331ex3119c3e33.htm EX-31.1 20292
4 EX-31.2 depo-20180331ex3128fa6e7.htm EX-31.2 22192
5 EX-32.1 depo-20180331ex3215a83f0.htm EX-32.1 9095
6 EX-32.2 depo-20180331ex322ccd869.htm EX-32.2 9607
  Complete submission text file 0001558370-18-004605.txt   11214777

Data Files

Seq Description Document Type Size
7 EX-101.INS depo-20180331.xml EX-101.INS 2384183
8 EX-101.SCH depo-20180331.xsd EX-101.SCH 76041
9 EX-101.CAL depo-20180331_cal.xml EX-101.CAL 85904
10 EX-101.DEF depo-20180331_def.xml EX-101.DEF 331976
11 EX-101.LAB depo-20180331_lab.xml EX-101.LAB 673921
12 EX-101.PRE depo-20180331_pre.xml EX-101.PRE 517923
Mailing Address 7999 GATEWAY BLVD. SUITE 300 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD. SUITE 300 NEWARK CA 94560 510-744-8000
DEPOMED INC (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 18821925
SIC: 2834 Pharmaceutical Preparations